Short Interest in Cansortium Inc. (OTCMKTS:CNTMF) Declines By 25.4%
Short Interest in Cansortium Inc. (OTCMKTS:CNTMF) Declines By 25.4%
Cansortium Inc. (OTCMKTS:CNTMF – Get Rating) was the target of a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 102,700 shares, a drop of 25.4% from the October 15th total of 137,700 shares. Based on an average daily trading volume, of 358,100 shares, the short-interest ratio is presently 0.3 days.
Cansortium Inc.(場外交易代碼：CNTMF-GET Rating)是空頭股數10月份大幅下跌的目標。截至10月31日，空頭股數共有102,700股，較10月15日的137,700股減少了25.4%。以日均成交量35.81萬股計算，目前短息比為0.3天。
Analyst Upgrades and Downgrades
分析師升級和下調評級
Separately, BTIG Research started coverage on shares of Cansortium in a research report on Friday, October 28th. They set a "buy" rating on the stock.
另外，BTIG Research在10月28日星期五的一份研究報告中開始報道Cansortium的股票。他們對該股設定了“買入”評級。
Cansortium Stock Performance
Cansortium股票表現
Shares of OTCMKTS CNTMF opened at $0.16 on Friday. Cansortium has a 52-week low of $0.13 and a 52-week high of $0.78. The company's 50 day moving average price is $0.18 and its 200-day moving average price is $0.18.
上週五，OTCMKTS CNTMF的股價開盤報0.16美元。Cansortium的52周低點為0.13美元，52周高位為0.78美元。該公司的50日移動均線價格為0.18美元，200日移動均線價格為0.18美元。
About Cansortium
關於Cansortium
Cansortium Inc, through its subsidiaries, produces and sells medical cannabis in the United States. The company engages in the cultivation, processing, retail, and distribution activities. Its medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, prerolls, cartridges, and edibles.
Cansortium Inc.通過其子公司在美國生產和銷售醫用大麻。該公司從事種植、加工、零售和分銷活動。它的醫用大麻產品以口服液、膠囊、栓劑、外用藥、注射器、乾花、預卷、藥筒和可食用的形式提供。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on Cansortium (CNTMF)
- MarketBeat: Week in Review 11/7 – 11/11
- Oil Is a Compelling Reason The Sell-Off In Stocks Isn't Over
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don't Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
- 免費獲取StockNews.com關於Cansortium的研究報告(CNTMF)
- MarketBeat：回顧中的一週11/7-11/11
- 油價是股市拋售尚未結束的一個令人信服的原因
- 中盤Neurocrine生物科學是井噴後的第三季度報告嗎？
- 六面旗幟是一種你不想被困住的旅程
- Hanesbrand可能發出零售類股本週表現不佳的信號
Receive News & Ratings for Cansortium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cansortium and related companies with MarketBeat.com's FREE daily email newsletter.
接受Cansortium Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Cansortium和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。